Caffeine as an analgesic adjuvant for acute pain in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2014, Pages

  Derry, Christopher J ^a   Derry, Sheena ^a   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; DICLOFENAC; IBUPROFEN; PARACETAMOL; TOLFENAMIC ACID; ANTHRANILIC ACID DERIVATIVE;

ADJUVANT THERAPY; ADULT; ANALGESIA; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; POSTPARTUM PAIN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; STUDY DESIGN; SYSTEMATIC REVIEW; TENSION HEADACHE; TOOTH PAIN; UNSPECIFIED SIDE EFFECT; ACUTE PAIN; ADJUVANT CHEMOTHERAPY; ADOLESCENT; AGED; DRUG POTENTIATION; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; PAIN, POSTOPERATIVE; PREGNANCY; PROCEDURES; PUERPERIUM;

ACETAMINOPHEN; ACUTE PAIN; ADOLESCENT; ADULT; AGED; ANALGESICS; CAFFEINE; CHEMOTHERAPY, ADJUVANT; DICLOFENAC; DRUG SYNERGISM; DYSMENORRHEA; FEMALE; HEADACHE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; ORTHO-AMINOBENZOATES; PAIN, POSTOPERATIVE; POSTPARTUM PERIOD; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991010587     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009281.pub3     Document Type: Review

References (68)

1. Ali Z, Burnett I, Eccles R, North M, Jawad M, Jawad S, et al. Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea. Current Medical Research and Opinion 2007;23(4):841-51. 3163175
2. Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clinical Pharmacology and Therapeutics 2000;68(3):312-9. 3163177
3. Diamond S, Freitag FG. The use of ibuprofen plus caffeine to treat tension-type headache. Current Pain and Headache Reports 2001;5(5):472-8. 3163178
4. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2005;25(10):776-87. 3163180
5. Pfaffenrath V, Diener HC, Pageler L, Peil H, Aicher B. OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial. Headache 2009;49(5):638-45. 3163181
6. Forbes JA, Jones KF, Kehm CJ, Smith WK, Gongloff CM, Zeleznock JR, et al. Evaluation of aspirin, caffeine, and their combination in postoperative oral surgery pain. Pharmacotherapy 1990;10(6):387-93. 3163183
7. Forbes JA, Beaver WT, Jones KF, Kehm CJ, Smith WK, Gongloff CM, et al. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clinical Pharmacology and Therapeutics 1991;49(6):674-84. 3163185
8. Laska EM, Sunshine A, Zighelboim I, Roure C, Marrero I, Wanderling J, et al. Effect of caffeine on acetaminophen analgesia. Clinical Pharmacology and Therapeutics 1983;33(4):498-509. 3163187
9. Laska EM, Sunshine A, Zighelboim I, Roure C, Marrero I, Wanderling J, et al. Effect of caffeine on acetaminophen analgesia. Clinical Pharmacology and Therapeutics 1983;33(4):498-509. 3163189
10. Laska EM, Sunshine A, Zighelboim I, Roure C, Marrero I, Wanderling J, et al. Effect of caffeine on acetaminophen analgesia. Clinical Pharmacology and Therapeutics 1983;33(4):498-509. 3163191
11. Laska EM, Sunshine A, Zighelboim I, Roure C, Marrero I, Wanderling J, et al. Effect of caffeine on acetaminophen analgesia. Clinical Pharmacology and Therapeutics 1983;33(4):498-509. 3163193
12. McQuay HJ, Angell K, Carroll D, Moore RA, Juniper RP. Ibuprofen compared with ibuprofen plus caffeine after third molar surgery. Pain 1996;66(2-3):247-51. 3163195
13. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clinical Pharmacology and Therapeutics 1994;56(5):576-86. 3163197
14. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clinical Pharmacology and Therapeutics 1994;56(5):576-86. 3163199
15. Peroutka SJ, Lyon JA, Swarbrick J, Lipton RB, Kolodner K, Goldstein J. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. Headache 2004;44(2):136-41. 3163201
16. Schachtel BP, Fillingim JM, Lane AC, Thoden WR, Baybutt RI. Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat. Archives of Internal Medicine 1991;151(4):733-7. 3163203
17. Sunshine A, Zighelboim I, Bartizek RD. A double-blind, placebo-controlled, single-dose comparison study of ibuprofen, and ibuprofen in combination with caffeine, in the treatment of postepisiotomy pain. Royal Society of Medicine International Congress and Symposium Series 218 1996;218:105-88. 3163205
18. Tokola RA, Kangasniemi P, Neuvonen PJ, Tokola O. Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia 1984;4(4):253-63. 3163207
19. Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain 1991;44(2):151-5. 3163209
20. Winter L Jr, Appleby F, Ciccone PE, Pigeon JG. A double-blind, comparative evaluation of acetaminophen, caffeine, and the combination of acetaminophen and caffeine in outpatients with post-operative oral surgery pain. Current Therapeutic Research 1983;33(1):115-22. 3163211
21. Wójcicki J, Samochowiec L, Lawczyński L, Szwed G, Olszewska M. A double-blind comparative evaluation of aspirin, paracetamol and paracetamol + caffeine (Finimal) for their analgesic effectiveness. Archivum Immunologiae et Therapiae Experimentalis 1977;25(2):175-9. 3163213
22. Wójcicki J, Samochowiec L, Lawczyński L, Szwed G, Olszewska M. A double-blind comparative evaluation of aspirin, paracetamol and paracetamol + caffeine (Finimal) for their analgesic effectiveness. Archivum Immunologiae et Therapiae Experimentalis 1977;25(2):175-9. 3163215
23. Anon. Citizen Petition Summary. http://www.fda.gov/ohrms/dockets/dockets/77n0094/77n-0094-cp00015_01.pdf (accessed 5 December 2014). 3163217
24. Jain AK, McMahon FG, Ryan JR, Narcisse C. A double-blind study of ibuprofen 200 mg in combination with caffeine 100 mg, ibuprofen 400 mg, and placebo in episiotomy pain. Current Therapeutic Research 1988;43(4):762-9. 3163219
25. Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A. Caffeine as an analgesic adjuvant. JAMA 1984;251(13):1711-8. 3163221
26. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clinical Pharmacology and Therapeutics 1994;56(5):576-86. 3163223
27. Mitchell A, van Zanten SV, Inglis K, Porter G. A randomized controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine after outpatient general surgery. Journal of the American College of Surgeons 2008;206(3):472-9. 3163225
28. Schachtel BP, Thoden WR, Konerman JP, Brown A, Chaing DS. Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents. Clinical Pharmacology & Therapeutics 1991;50(3):322-9. 3163227
29. Comparison of analgesic effect - the combination of acetaminophen and ibuprofen in the presence and absence of caffeine on pain after root canal treatment. who.int/trialsearch/Trial2.aspx?TrialID=IRCT201306121760N24 2014 (accessed 28 August 2014). [IRCT: IRCT201306121760N24]3163229
30. Maxalt 10 mg plus caffeine 75 mg in the acute treatment of migraine headache. clinicaltrials.gov/ct2/results?term=NCT00471952&Search=Search 2014 (accessed 28 August 2014). [NCT: NCT00471952]3163231
31. Efficacy and safety study to compare ibuprofen + caffeine with ibuprofen alone in the treatment of headache. clinicaltrials.gov/ct2/results?term=NCT01172405&Search=Search 2014 (accessed 28 August 2014). [NCT: NCT01172405]3163233
32. A single-centre, double-blind, randomised, two-stage, parallel-group study to assess the efficacy and safety of the fixed dose combination of ibuprofen 400 mg and caffeine 100 mg versus ibuprofen 400 mg, caffeine 100 mg and placebo in patients with postoperative dental pain. clinicaltrials.gov/ct2/results?term=NCT01929031&Search=Search 2014 (accessed 28 August 2014). [NCT: NCT01929031]3163235
33. Acetylsalicylic acid (ASA) + paracetamol + caffeine combination compared with ASA + paracetamol as well as ASA, paracetamol, and caffeine in headache patients. clinicaltrials.gov/ct2/show/NCT02183688?term=NCT02183688&rank=1 2014 (accessed 28 August 2014). [NCT: NCT02183688]3163237
34. Basurto Ona X, Uriona Tuma SM, Martínez García L, Solà I, Bonfill Cosp X. Drug therapy for preventing post-dural puncture headache. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD001792.pub3]
35. Beaver WT. Caffeine revisited. JAMA 1984;251(13):1732-3.
36. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310(6977):452-4.
37. Cooper SA. Single-dose analgesic studies: the upside and downside of assay sensitivity. The Design of Analgesic Clinical Trials. Advances in Pain Research Therapy 1991;18:117-24.
38. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:f2304. [DOI: 10.1136/bmj.f2304]
39. Donovan JL, DeVane CL. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Psychopharmacology Bulletin 2001;35(3):30-48.
40. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Jadad AR, Carroll D, Moore RA, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2-3):239-46.
42. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
43. Jain AK, McMahon FG, Ryan JR, Unger D, Richard W. Aspirin and aspirin-caffeine in postpartum pain relief. Clinical Pharmacology and Therapeutics 1978;24(1):69-75.
44. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 2004;176(1):1-29. [DOI: 10.1007/s00213-004-2000-x]
45. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
46. Li Wan Po A, Zhang WY. Analgesic efficacy of ibuprofen alone and in combination with codeine or caffeine in post-surgical pain: a meta-analysis. European Journal of Clinical Pharmacology 1998;53:303-11.
47. McQuay HJ, Moore RA. Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies. British Journal of Clinical Pharmacology 2007;63(3):271-8. [DOI: 10.1111/j.1365-2125.2006.02723.x]
48. Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66(2-3):229-37. [DOI: 10.1016/0304-3959(96)03032-1]
49. Moore A, Moore O, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain 1997;69(3):311-5. [DOI: 10.1016/S0304-3959(96)03306-4]
50. Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data. Pain 1997;69(1-2):127-30. [DOI: 10.1016/S0304-3959(96)03251-4]
51. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
52. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
53. Moore RA, Derry S, Wiffen PJ, Straube S, Bendtsen L. Evidence for efficacy of acute treatment of episodic tension-type headache: methodological critique of randomised trials for oral treatments. Pain 2014 Aug 17 [Epub ahead of print]. [DOI: 10.1016/j.pain.2014.08.009]
54. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratio and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with Confidence - Confidence Intervals and Statistical Guidelines. London: BMJ Books, 1995:50-63.
55. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515. [DOI: 10.1136/bmj.c3515]
56. Palmer H, Graham G, Williams K, Day R. A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine. Pain Medicine 2010;11(6):951-65. [DOI: 10.1111/j.1526-4637.2010.00867.x]
57. Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U, et al. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. Journal of Clinical Pharmacology 2007;47(6):715-26.
58. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
59. Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacological Reviews 1993;45(1):43-85.
60. Sawynok J. Methylxanthines and pain. Handbook of Experimental Pharmacology 2011;200:311-29. [DOI: 10.1007/978-3-642-13443-2_11]
61. Sawynok J. Caffeine and pain. Pain 2011;152(4):726-9. [DOI: 10.1016/j.pain.2010.10.011]
62. Sawynok J, Reid AR. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting3 spinal adenosine A1 receptors. European Journal of Pharmacology 2011 Nov 7 [Epub ahead of print]. [DOI: 10.1016/j.ejphar.2011.10.036]
63. Schachtel BP, Fillingim JM, Lane AC, Thoden WR, Baybutt RI. Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat. Archives of Internal Medicine 1991;151(4):733-7.
64. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate results on meta-analysis: a case study. BMJ 1997;315(7109):635-40.
65. Zhang WY, Li Wan Po A. Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain - a meta-analysis. Journal of Clinical Pharmacology and Therapeutics 1996;21(4):261-82.
66. Zhang WY, Po AL. Do codeine and caffeine enhance the analgesic effect of aspirin? A systematic overview. Journal of Clinical Pharmacology and Therapeutics 1997;22(2):79-97.
67. Zhang WY. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Safety 2001;24(15):1127-42.
68. Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD009281.pub2]